Iterative Therapeutics Inc.

Biotechnology company · Chicago, Illinois, United States

Iterative Therapeutics Inc. is a biotechnology company headquartered in Chicago, Illinois, United States. It has received 5 US government small-business research awards (SBIR/STTR) from health agencies, $1.5 million in total, most recently in 2017.

Profile compiled from public records. Is this your company? Request a correction or update

Iterative Therapeutics at a glance

Typebiotechnology company
HeadquartersChicago, Illinois, United States

What does Iterative Therapeutics do?

US government research funding

5 SBIR/STTR small-business research awards from US health agencies, $1.5 million in total (2004 to 2017). NIH funding came from the National Cancer Institute.

Frequently asked questions about Iterative Therapeutics

Where is Iterative Therapeutics headquartered?

Iterative Therapeutics Inc. is headquartered in Chicago, Illinois, United States.

What does Iterative Therapeutics do?

Iterative Therapeutics Inc. is a biotechnology company.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences